HRP20100208T8 - Method of treating acute rhinosinusitis - Google Patents
Method of treating acute rhinosinusitisInfo
- Publication number
- HRP20100208T8 HRP20100208T8 HR20100208T HRP20100208T HRP20100208T8 HR P20100208 T8 HRP20100208 T8 HR P20100208T8 HR 20100208 T HR20100208 T HR 20100208T HR P20100208 T HRP20100208 T HR P20100208T HR P20100208 T8 HRP20100208 T8 HR P20100208T8
- Authority
- HR
- Croatia
- Prior art keywords
- treating acute
- acute rhinosinusitis
- treating
- disease
- rhinosinusitis
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 206010001076 Acute sinusitis Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 229960002744 mometasone furoate Drugs 0.000 abstract 1
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 238000009097 single-agent therapy Methods 0.000 abstract 1
- 201000009890 sinusitis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53783004P | 2004-01-21 | 2004-01-21 | |
| PCT/US2005/002105 WO2005072704A2 (en) | 2004-01-21 | 2005-01-19 | Method of treating acute rhinosinusitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP20100208T1 HRP20100208T1 (hr) | 2010-05-31 |
| HRP20100208T8 true HRP20100208T8 (en) | 2010-06-30 |
Family
ID=34825945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20100208T HRP20100208T8 (en) | 2004-01-21 | 2010-04-13 | Method of treating acute rhinosinusitis |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20050186144A1 (xx) |
| EP (2) | EP2201936B1 (xx) |
| JP (2) | JP4976139B2 (xx) |
| AT (1) | ATE461693T1 (xx) |
| CA (1) | CA2554064A1 (xx) |
| CY (1) | CY1110620T1 (xx) |
| DE (1) | DE602005020113D1 (xx) |
| DK (1) | DK1711164T3 (xx) |
| ES (2) | ES2340777T3 (xx) |
| HR (1) | HRP20100208T8 (xx) |
| MX (1) | MXPA06008240A (xx) |
| PL (1) | PL1711164T3 (xx) |
| PT (1) | PT1711164E (xx) |
| RS (1) | RS51335B (xx) |
| SI (1) | SI1711164T1 (xx) |
| WO (1) | WO2005072704A2 (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA06008240A (es) * | 2004-01-21 | 2006-08-31 | Schering Corp | Metodos de tratamiento. |
| US20090325917A1 (en) * | 2006-10-19 | 2009-12-31 | Cipla Limited | Pharmaceutical Compositions and Nasal Spray Incorporating Anhydrous Mometasone Furoate |
| TWI411121B (zh) * | 2010-03-11 | 2013-10-01 | Ind Tech Res Inst | 光吸收層之製造方法及應用其之太陽能電池結構 |
| US9744210B2 (en) | 2012-12-27 | 2017-08-29 | Massachusetts Eye & Ear Infirmary | Treatment of rhinosinusitis with P-glycoprotein inhibitors |
| JP7085485B2 (ja) | 2016-01-15 | 2022-06-16 | マサチューセッツ アイ アンド イヤー インファーマリー | 分泌型ｐ－糖タンパク質は、慢性鼻副鼻腔炎の非侵襲的バイオマーカーである |
| CN116209449A (zh) * | 2020-06-21 | 2023-06-02 | 麻省眼耳科医院 | 用于慢性鼻窦炎治疗的维拉帕米和莫米松联合疗法 |
| JP2024049405A (ja) * | 2021-02-22 | 2024-04-10 | 興和株式会社 | 新規吸入剤 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CY1359A (en) | 1981-02-02 | 1987-08-07 | Schering Corp | Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them |
| US4731447A (en) * | 1985-05-13 | 1988-03-15 | Schering Corporation | Process for preparing piperidylidene dihydro-dibenzo(a,d)-cycloheptenes or aza-derivatives thereof |
| US4873335A (en) * | 1986-03-12 | 1989-10-10 | Schering Corporation | 3-phenethyl-2-benzene-amides or aza-derivatives thereof |
| ATE246497T1 (de) | 1991-06-10 | 2003-08-15 | Schering Corp | Fluorchlorkohlenwasserstoffreie aerosolformulierungen |
| EP0518601A1 (en) * | 1991-06-10 | 1992-12-16 | Schering Corporation | Non-chlorofluorocarbon aerosol formulations |
| US6127353A (en) | 1991-09-06 | 2000-10-03 | Schering Corporation | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| US5837699A (en) * | 1994-01-27 | 1998-11-17 | Schering Corporation | Use of mometasone furoate for treating upper airway passage diseases |
| PE44995A1 (es) * | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
| US6068832A (en) | 1996-08-29 | 2000-05-30 | Schering Corporation | Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| US5837713A (en) * | 1997-02-26 | 1998-11-17 | Mayo Foundation For Medical Education And Research | Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids |
| US6503537B2 (en) * | 1997-03-20 | 2003-01-07 | Schering Corporation | Preparation of powder agglomerates |
| US6495167B2 (en) * | 1997-03-20 | 2002-12-17 | Schering Corporation | Preparation of powder agglomerates |
| US6187765B1 (en) | 1997-10-09 | 2001-02-13 | Schering Corporation | Mometasone furoate suspensions for nebulization |
| US6297227B1 (en) * | 1998-09-10 | 2001-10-02 | Schering Corporation | Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines |
| SE9803770D0 (sv) * | 1998-11-05 | 1998-11-05 | Astra Ab | Dry powder pharmaceutical formulation |
| US6465581B1 (en) * | 2001-01-24 | 2002-10-15 | The Goodyear Tire & Rubber Company | Silica reinforced rubber composition which contains stabilized unsymmetrical coupling agents and article of manufacture, including a tire, having at least one component comprised of such rubber composition |
| TWI324934B (en) * | 2001-08-28 | 2010-05-21 | Schering Corp | Pharmaceutical compositions for the treatment of asthma |
| ES2281691T3 (es) * | 2002-08-23 | 2007-10-01 | Schering Corporation | Composiciones farmaceuticas. |
| US20040081625A1 (en) * | 2002-10-21 | 2004-04-29 | Schering Corporation | Nasal formulations for the treatment of allergies |
| US8912174B2 (en) * | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
| US20040235807A1 (en) * | 2003-05-21 | 2004-11-25 | Weinrich Karl P. | Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea |
| CN1870976A (zh) * | 2003-10-20 | 2006-11-29 | 先灵公司 | 药物组合物 |
| MXPA06008240A (es) * | 2004-01-21 | 2006-08-31 | Schering Corp | Metodos de tratamiento. |
| US8615310B2 (en) | 2010-12-13 | 2013-12-24 | Pacesetter, Inc. | Delivery catheter systems and methods |
| US9106249B1 (en) | 2014-09-04 | 2015-08-11 | Semtech Corporation | Calibration of a time-interleaved analog-to-digital converter |
-
2005
- 2005-01-19 MX MXPA06008240A patent/MXPA06008240A/es active IP Right Grant
- 2005-01-19 DE DE602005020113T patent/DE602005020113D1/de active Active
- 2005-01-19 EP EP10003076.6A patent/EP2201936B1/en not_active Revoked
- 2005-01-19 PT PT05711867T patent/PT1711164E/pt unknown
- 2005-01-19 JP JP2006551345A patent/JP4976139B2/ja not_active Expired - Fee Related
- 2005-01-19 WO PCT/US2005/002105 patent/WO2005072704A2/en active Application Filing
- 2005-01-19 ES ES05711867T patent/ES2340777T3/es active Active
- 2005-01-19 ES ES10003076T patent/ES2426957T3/es active Active
- 2005-01-19 PL PL05711867T patent/PL1711164T3/pl unknown
- 2005-01-19 CA CA002554064A patent/CA2554064A1/en not_active Abandoned
- 2005-01-19 US US11/038,343 patent/US20050186144A1/en not_active Abandoned
- 2005-01-19 SI SI200531000T patent/SI1711164T1/sl unknown
- 2005-01-19 RS RSP-2010/0236A patent/RS51335B/en unknown
- 2005-01-19 AT AT05711867T patent/ATE461693T1/de active
- 2005-01-19 EP EP05711867A patent/EP1711164B1/en active Active
- 2005-01-19 DK DK05711867.1T patent/DK1711164T3/da active
-
2008
- 2008-01-28 JP JP2008016970A patent/JP2008110991A/ja active Pending
- 2008-07-11 US US12/171,989 patent/US20090022671A1/en not_active Abandoned
-
2010
- 2010-04-13 HR HR20100208T patent/HRP20100208T8/xx unknown
- 2010-04-28 CY CY20101100378T patent/CY1110620T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI1711164T1 (sl) | 2010-06-30 |
| ES2426957T3 (es) | 2013-10-28 |
| EP2201936A1 (en) | 2010-06-30 |
| WO2005072704A3 (en) | 2006-07-20 |
| US20050186144A1 (en) | 2005-08-25 |
| WO2005072704A2 (en) | 2005-08-11 |
| RS51335B (en) | 2011-02-28 |
| ATE461693T1 (de) | 2010-04-15 |
| JP2007518817A (ja) | 2007-07-12 |
| MXPA06008240A (es) | 2006-08-31 |
| DK1711164T3 (da) | 2010-07-19 |
| ES2340777T3 (es) | 2010-06-09 |
| HRP20100208T1 (hr) | 2010-05-31 |
| US20090022671A1 (en) | 2009-01-22 |
| EP2201936B1 (en) | 2013-06-19 |
| EP1711164A2 (en) | 2006-10-18 |
| CA2554064A1 (en) | 2005-08-11 |
| DE602005020113D1 (de) | 2010-05-06 |
| JP4976139B2 (ja) | 2012-07-18 |
| JP2008110991A (ja) | 2008-05-15 |
| PL1711164T3 (pl) | 2010-09-30 |
| CY1110620T1 (el) | 2015-04-29 |
| PT1711164E (pt) | 2010-06-28 |
| EP1711164B1 (en) | 2010-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20100208T8 (en) | Method of treating acute rhinosinusitis | |
| IL249715B (en) | N-butyl-deoxynojirimycin for use as a drug for the treatment of Pompe disease in combination with an enzyme replacement therapy agent | |
| LU92232I9 (xx) | ||
| WO2006078463A3 (en) | Method for treating cardiovascular disease | |
| WO2006047631A3 (en) | Anti-mitotic anti-proliferative compounds | |
| WO2003096977A3 (en) | Methods of treating hepatitis | |
| WO2007124461A8 (en) | Glp-1 compounds | |
| WO2007146965A3 (en) | Compounds for the treatment of periodontal disease | |
| PT2383271E (pt) | Aminoquinolonas como inibidores de gsk-3 | |
| PL2380584T3 (pl) | Sposób do immunostymulacji | |
| TW200738270A (en) | Method of treating depression using a TNFα antibody | |
| WO2006085149A3 (en) | Methods and compositions for treating amyloid-related diseases | |
| WO2003088923A3 (en) | Methods of treating ileus | |
| HK1166465A1 (en) | 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position as parp inhibitors for use in treating cancer | |
| JP2008535798A5 (xx) | ||
| WO2007143607A3 (en) | Method of treating atrophic vaginitis | |
| IL180931A0 (en) | Medicaments for treating chronic respiratory disease | |
| IL188176A0 (en) | Stable pharmaceutical composition comprising linezolid form iv | |
| CY1112727T1 (el) | Παραγωγα κυκλοβουτυλ αμινης βενζοθειαζολης και η χρηση αυτων ως προσδετες των υποδοχεων ισταμινης-3 | |
| WO2008063768A3 (en) | Compositions and methods for treating metabolic diseases | |
| WO2005051331A3 (en) | Chaperone-based therapy for niemann-pick disease | |
| WO2006078713A3 (en) | Methotrexate combinations for treating inflammatory diseases | |
| WO2007084743A3 (en) | Intraventricular protein delivery for amyotrophic lateral sclerosis | |
| WO2008019388A3 (en) | Milnacipran for the treatment of fatigue associated with fibromyalgia syndrome | |
| WO2008016665A3 (en) | Imidazoacridine compounds for treating flt3 -mediated disorders |